95C-16367-19374
4 vaccinations
7 coded responses
27 check-ins
7 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 51-55
- ZIP prefix
- 276 / NC
- Registered
- 2020-12-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-18
Registered in v-safe
-
2020-12-18
Dose 1 — Pfizer-BioNTech
- 2020-12-18
-
2020-12-19
Survey response — days 1–6 daily, dose 1MedDRA: Headache — Feeling: Good · Site: PainFree text: Mild headache 3 to 4 hours after receiving the vaccine. It subsided after about 1.5 to 2 hours.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-20
Survey response — days 1–6 daily, dose 1MedDRA: Abdominal pain, Injection site reaction, Muscle tightness — Feeling: GoodFree text: Abdominal cramps but nothing painful. Muscle tightness in R shoulder (site injection).MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-21
- 2020-12-22
- 2020-12-23
-
2020-12-24
Survey response — days 1–6 daily, dose 1MedDRA: Nasal congestion, Rhinorrhoea — Feeling: GoodFree text: Nasal drainage earlier today but now stuffinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-25
Survey response — day 7, dose 1MedDRA: Ageusia, Anosmia, Productive cough, Respiratory tract congestion — Feeling: Good · Muscle or body aches, DiarrheaFree text: Temporary loss of taste and smell, small amount of chest congestion/phlegmMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-01
Survey response — day 14, dose 1MedDRA: COVID-19 — Feeling: FairFree text: Diagnosed with COVID on 12/29/2020.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-08
-
2021-01-14
Dose 2 — Pfizer-BioNTech
-
2021-01-15
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-20
- 2021-01-21
- 2021-01-28
- 2021-02-04
- 2021-02-11
- 2021-02-18
- 2021-02-25
- 2021-04-15
-
2021-07-15
Survey response — 6 months, dose 2MedDRA: Office visit, Pityriasis rosea — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Diagnosed with pityriasis rosea. Tryi to determine if its vaccine related or from having COVID. · Healthcare visit (other): DermatologistMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-15
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-22
-
2021-07-22
Call successfulReported to VAERS voluntarily prior to GDIT contact
-
2021-12-31
Dose 3 — Pfizer-BioNTech
- 2022-01-14
-
2022-07-01
Survey response — 6 months, dose 3MedDRA: Office visit, Pityriasis rosea — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Persistent pityriasis rosea that has been ongoing now for over 15 months. · Healthcare visit (other): DermatologistMedDRA releases: 2024-11 · check-in free text available
-
2022-07-01
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professional1 call case(s)
-
2022-07-05
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-08-05
Dose 4 — Pfizer-BioNTech
- 2022-11-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-14 | Pfizer-BioNTech | |
| 3 | 2021-12-31 | Pfizer-BioNTech | No |
| 4 | 2022-08-05 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
VAERS report filed, before or during a call: 1
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Mild headache 3 to 4 hours after receiving the vaccine. It subsided after about 1.5 to 2 hours.
Systemic reaction (other): Abdominal cramps but nothing painful. Muscle tightness in R shoulder (site injection).
Systemic reaction (other): Nasal drainage earlier today but now stuffiness
Release 1 — day 7, dose 1
Systemic reaction (other): Temporary loss of taste and smell, small amount of chest congestion/phlegm
Release 1 — day 14, dose 1
Symptoms: Diagnosed with COVID on 12/29/2020.
Release 9 — 6 months, dose 2
Symptoms: Diagnosed with pityriasis rosea. Tryi to determine if its vaccine related or from having COVID.
Healthcare visit (other): Dermatologist
Release 12 — 6 months, dose 3
Symptoms: Persistent pityriasis rosea that has been ongoing now for over 15 months.
Healthcare visit (other): Dermatologist
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | · | ✓ |
| SD | COVID-19 | ✓ | ✓ | ✓ |
| SD | Pityriasis rosea | ✓ | · | ✓ |
| SRO | Abdominal pain | ✓ | ✓ | ✓ |
| SRO | Ageusia | ✓ | ✓ | ✓ |
| SRO | Anosmia | ✓ | ✓ | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Injection site reaction | ✓ | ✓ | ✓ |
| SRO | Muscle tightness | ✓ | ✓ | ✓ |
| SRO | Nasal congestion | ✓ | ✓ | ✓ |
| SRO | Productive cough | ✓ | ✓ | ✓ |
| SRO | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release